Treatment of rhinitis medicamentosa with fluticasone propionate--an experimental study.

The efficacy of fluticasone propionate aqueous nasal spray (0.05% w/w) in the treatment of rhinitis medicamentosa has been studied in an animal model (guinea pig). Rhinitis medicamentosa was induced through the instillation of 0.05% naphthazoline nitrate (Privine) for 8 weeks. Fluticasone propionate nasal spray was then administered to the animals for 2 weeks. The spray successfully cleared the interstitial edema which is the pathologic hallmark of rhinitis medicamentosa. The study suggests that fluticasone propionate nasal spray can be beneficial in the treatment of patients with rhinitis medicamentosa.
AuthorsS Elwany, S Abdel-Salaam
JournalEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (Eur Arch Otorhinolaryngol) Vol. 258 Issue 3 Pg. 116-9 (Mar 2001) ISSN: 0937-4477 [Print] Germany
PMID11374251 (Publication Type: Journal Article)
Chemical References
  • Androstadienes
  • Nasal Decongestants
  • Fluticasone
  • Naphazoline
  • Administration, Intranasal
  • Androstadienes (administration & dosage, adverse effects)
  • Animals
  • Disease Models, Animal
  • Drug Hypersensitivity (drug therapy, pathology)
  • Fluticasone
  • Guinea Pigs
  • Microscopy, Electron
  • Naphazoline (toxicity)
  • Nasal Decongestants (toxicity)
  • Nasal Mucosa (drug effects, pathology)
  • Rhinitis (chemically induced, drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: